Delivery Order SPE2DB20D2014-SPE2DB24FB26Z
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,089,587 units of Epinephrine 0.3 mg auto-injector devices. The $4,485.90 award has a completion date of March 28, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp holds a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical as the prime...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,816,842 units of Epinephrine 0.3 mg auto-injectors. The $3,792.76 contract has a performance period through March 1, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,259,971 units of Epinephrine 0.3 mg auto-injector 2-packs. The $1,068.63 contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, that...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,547,771 units of Epinephrine 0.3 mg auto-injectors. The contract has a potential value of $2,708.88 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,592.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,727,625 units of Epinephrine 0.3 mg auto-injector 2-packs. The contract has a firm fixed price and an ultimate completion date of December 17, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), is the prime contractor with no set-aside designation...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,261,737 units of Epinephrine 0.3 mg auto-injector two-packs. The contract has a ceiling value of $5,087.80 and a period of performance through April 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $11,223.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,162,774 units of 0.3 mg epinephrine auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,184,277 units of Epinephrine 0.3 mg auto-injectors. The $11,219.50 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Epinephrine 0.3 mg auto-injectors. The $1,256.06 contract has a performance period through January 26, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceutical products and medical supplies to support military treatment programs and facilities. This...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,373.67 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,556,974,597 units of Epinephrine 0.3 mg auto-injectors. This contract has an ultimate completion date of April 25, 2022 and was not designated with a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB26ZDelivery Order
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,900,396 units of the Epinephrine 0.3 mg auto-injector product. The $1,688.23 contract has a performance period through March 11, 2024 and does not have a set-aside designation. This award is issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. AmerisourceBergen Drug Corp, as the prime contractor, is responsible for delivering these critical epinephrine auto-injectors to support military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 3/8/24 |